SCHEMBL6218249

SCHEMBL6218249

O=C1[N]c2c(I)cc(C(F)(F)F)cc2N1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
IKBKB O14920 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6221255 0.80 ALDH1A1 (0.36) IKBKB
SCHEMBL6220507 0.80 GRM2 (0.31) IKBKB
SCHEMBL6220260 0.80 JUN (0.35)
SCHEMBL6219443 0.75 ALDH1A1 (0.49) KMT2AMEN1
SCHEMBL6223305 0.73 PDE3B (0.34)
SCHEMBL4750486 0.69 GRM2 (0.42) KMT2AMEN1
SCHEMBL6179642 0.68 CES1 (0.41) KMT2AMEN1
SCHEMBL6222347 0.67 KIF11 (0.41) KMT2A
SCHEMBL4752992 0.67 KIF11 (0.41) KMT2A
SCHEMBL24355256 0.67 GSK3B (0.44) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551811-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS Amgen Inc. (US) 2005-07-13 EP disclosed
WO-2004035549-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS AMGEN INC. (US) 2004-04-29 WO disclosed